162 related articles for article (PubMed ID: 2053325)
1. In vitro evaluation of buffy-coat-derived platelet concentrates stored in a synthetic medium.
Fijnheer R; Veldman HA; van den Eertwegh AJ; Gouwerok CW; Homburg CH; Boomgaard MN; de Korte D; Roos D
Vox Sang; 1991; 60(1):16-22. PubMed ID: 2053325
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods.
Fijnheer R; Pietersz RN; de Korte D; Gouwerok CW; Dekker WJ; Reesink HW; Roos D
Transfusion; 1990 Sep; 30(7):634-8. PubMed ID: 2144922
[TBL] [Abstract][Full Text] [Related]
3. A novel technique for preparing improved buffy coat platelet concentrates.
Mrowiec ZR; Oleksowicz L; Dutcher JP; De Leon-Fernandez M; Lalezari P; Puszkin EG
Blood Cells Mol Dis; 1995; 21(1):25-33. PubMed ID: 7655858
[TBL] [Abstract][Full Text] [Related]
4. Quality of pooled platelet concentrates prepared from buffy coats and stored in an additive solution after filtration.
Koerner K; Weihe R; Sahlmen P; Zeller B; Seifried E; Cardoso M; Kubanek B
Ann Hematol; 1995 Feb; 70(2):97-102. PubMed ID: 7880932
[TBL] [Abstract][Full Text] [Related]
5. Buffy coat platelets stored in apyrase, aprotinin, and ascorbic acid in a suspended bag: combined strategies for reducing platelet activation during storage.
Mrowiec ZR; Oleksowicz L; Zuckerman D; De Leon-Fernandez M; Khorshidi M; Dutcher JP; Puszkin EG
Transfusion; 1996 Jan; 36(1):5-10. PubMed ID: 8607153
[TBL] [Abstract][Full Text] [Related]
6. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
[TBL] [Abstract][Full Text] [Related]
7. Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells: A comparison of fresh versus three types of platelet lysates from outdated buffy coat-derived platelet concentrates.
Glovinski PV; Herly M; Mathiasen AB; Svalgaard JD; Borup R; Talman MM; Elberg JJ; Kølle ST; Drzewiecki KT; Fischer-Nielsen A
Cytotherapy; 2017 Feb; 19(2):222-234. PubMed ID: 27887865
[TBL] [Abstract][Full Text] [Related]
8. Platelets stored in a glucose-free additive solution or in autologous plasma--an ultrastructural and morphometric evaluation.
Klinger MH; Josch M; Klüter H
Vox Sang; 1996; 71(1):13-20. PubMed ID: 8837351
[TBL] [Abstract][Full Text] [Related]
9. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
10. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
[TBL] [Abstract][Full Text] [Related]
11. Storage of platelet concentrates from overnight-stored blood and overnight-stored buffy coat: in vitro studies.
Rácz Z; Baróti C
Vox Sang; 1995; 68(3):160-3. PubMed ID: 7625072
[TBL] [Abstract][Full Text] [Related]
12. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
[TBL] [Abstract][Full Text] [Related]
13. Survival in vivo of platelets stored for 48 hours in the buffycoat at 4 degrees C compared to platelet rich plasma stored at 22 degrees C.
Pietersz RN; Loos JA; Reesink HW
Blut; 1987 Apr; 54(4):201-6. PubMed ID: 3828537
[TBL] [Abstract][Full Text] [Related]
14. Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reduction.
Isola H; Ravanat C; Rudwill F; Pongerard A; Haas D; Eckly A; Gachet C; Hechler B
Transfusion; 2021 Mar; 61(3):919-930. PubMed ID: 33527430
[TBL] [Abstract][Full Text] [Related]
15. Prevention of acquired defects in platelet function during blood processing.
Washitani Y; Irita Y; Yamamoto K; Shiraki H; Kiyokawa H; Maeda Y; Yoshinari M
Transfusion; 1988; 28(6):571-5. PubMed ID: 3194931
[TBL] [Abstract][Full Text] [Related]
16. The evolution of platelet procoagulant activity of remnant platelets in stored platelet concentrates prepared by the platelet-rich plasma method and the buffy coat method.
Van der Planken MG; Vertessen F; Mortelmans E; Van Bockstaele D; Muylle L; Mertens G; Berneman ZN
Ann Hematol; 1999 Jan; 78(1):1-7. PubMed ID: 10037261
[TBL] [Abstract][Full Text] [Related]
17. Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Porretti L; Murphy S
Transfusion; 1992 Jan; 32(1):9-16. PubMed ID: 1731448
[TBL] [Abstract][Full Text] [Related]
18. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of platelet concentrates, prepared from pooled buffy coats, stored for 8 days after filtration.
Boomgaard MN; Joustra-Dijkhuis AM; Gouwerok CW; Steneker I; Reesink HW; Loos JA; Pietersz RN; de Korte D
Transfusion; 1994 Apr; 34(4):311-6. PubMed ID: 8178328
[TBL] [Abstract][Full Text] [Related]
20. Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage.
Lozano M; Estebanell E; Cid J; Diaz-Ricart M; Mazzara R; Ordinas A; Escolar G
Transfusion; 1999 Sep; 39(9):951-9. PubMed ID: 10533821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
